Congenital Neurologic Anomalies are the birth defect of the physical structure of the brain and spinal cord. Congenital Neurologic Anomalies is caused by abnormal ontogenetic development of the fetus and occur during fetal intrauterine growth. There are different type of anomaly occurs by abnormal ontogenetic development such as malformation which is caused by abnormal development of the tissue and organ, Dysplasia is caused by the irregular arrangement of the cells, deformation is caused by abnormal physical force which damages tissue and organ and disruption also caused by a destructive process which affects organ and tissues. Anencephaly (Partial absence of the cranial vault), encephalocele (Herniation of the brain or meninges through a defect in the skull), spina bifida (Defects in the closure of the spinal column) are the most serious neurologic anomalies which are developed in the first two months of gestation. Congenital Neurologic Anomalies also occur by Teratogen which affects to normal ontogenic development during the fetal intrauterine growth and leads to Congenital Neurologic Anomalies. Genetic factor, environmental factor, and other factors also causes Congenital Neurologic Anomalies. Smoking, vitamins, Drugs, alcohol and other toxic substance infect the infant during fetal intrauterine growth. The neural tube usually fuses 18–26 days after ovulation and its defect lead Congenital Neurologic Anomalies. Congenital Neurologic Anomalies diagnosis is the only way to prevent anomalies or malformation before the development. There is two method involved in the diagnosis of Congenital Neurologic Anomalies. One is Invasive methods and another one is Noninvasive methods.
Globally increasing incidence and prevalence of Neurologic Anomalies and fetal infections are the major factors driving the growth of the Congenital Neurologic Anomalies market. Innovative new diagnosis techniques for Congenital Neurologic Anomalies such as Invasive and Noninvasive methods is expected to increase the acceptance of Congenital Neurologic Anomalies diagnosis market. Prenatal Ultrasonography or Targeted ultrasonography which is recommended by the expert for all pregnant woman, for the detection of Neurologic Anomalies such as short-limbed skeletal dysplasia and others, is anticipated to boost the growth of Congenital Neurologic Anomalies Market. Fetal chromosome abnormalities detection by the Noninvasive method also expected to contribute significantly to Congenital Neurologic Anomalies market growth. Apart from that other invasive method such as CVS, Cordocentesis, Fetoscopy, and fetal biopsy and biochemical screening with the help of maternal serum is also a growth factor for the Congenital Neurologic Anomalies market. The increasing demand for a customized Congenital Neurologic Anomalies diagnosis with the specifications and other imaging methods and these are the key factors anticipated to propel the demand for Congenital Neurologic Anomalies worldwide.
The Global Congenital Neurologic Anomalies market is segmented on the basis of Test type and by End user
Based on the Test type Congenital Neurologic Anomalies market is segmented as:
Based on the end user Congenital Neurologic Anomalies market is segmented as:
Rapidly increasing Central nervous system malformations is the major driver in the Congenital Neurologic Anomalies market. The global Congenital Neurologic Anomalies market by Invasive method Test type is expected to be dominated by the Amniocentesisdue and Chorionic villus sampling to higher adoption by pregnant women for Congenital Neurologic Anomalies testing. By end user, Congenital Neurologic Anomalies market is expected to be dominated by Diagnostic and research laboratories and hospitals due to higher User footfall for the Congenital Neurologic Anomalies. The manufacturers in the Congenital Neurologic Anomalies market are focusing on manufacturing advanced technology for better patient compliance and make the procedure easier.
The global Congenital Neurologic Anomalies market is expected to be dominated by North America due to higher adoption of new technology and significant development in the reimbursement policies. Europe is expected to be the second most lucrative Congenital Neurologic Anomalies market due to rising government funds for research and high risk of chromosomal disorders with increasing maternal age. Asia-Pacific is expected to be the fastest growing Congenital Neurologic Anomalies market due to the rapidly growing incidence of late pregnancies. Latin America and Middle East & Africa is expected to be the least lucrative market due to Low awareness and government initiative and established healthcare infrastructure in Congenital Neurologic Anomalies market.
Examples of some of the market participants in the global Congenital Neurologic Anomalies market identified are: Thermo Fisher Scientific, Inc, F. Hoffmann-La Roche AG, CooperSurgical, Inc, Bioarray S.L, Reproductive Health Science Ltd., SciGene Corporation, Agilent Technologies, Inc, Beijing Genomics Institute, Medline Industries, Medtronic, Becton, Dickinson and Company, Integra Lifesciences, and among others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
Regional analysis includes